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0 Abstract-Several investigators have recently developed 
guidelines for determining which patients with tricyclic an- 
tidepressant overdose should be hospitalized. The width of 
the QRS complex on the ECG and several clinical parame- 
ters have been proposed to identify patients at risk for ma- 
jor complications. To validate these, we developed an algo- 
rithm and then applied it to 45 patients who had overdosed 
on tricyclic antidepressants. This algorithm correctly pre- 
dicted which patients required admission, whether due to 
present or impending complications, and which patients 
could have been discharged without morbidity or mortality. 
We conclude that use of the modified algorithm can identi- 
fy patients with tricyclic antidepressant overdose who can 
be safely discharged from the emergency department. 
0 Keywords- algorithm; tricyclic; antidepressant; 
overdose; complications 
INTRODUCTION 
Tricyclic antidepressant (TCA) overdose may cause 
life-threatening complications. Most patients with 
TCA overdose are admitted to an intensive care unit 
because criteria for identifying patients who will have 
an uncomplicated course after TCA overdose have 
not been available.r-6 
Two investigators have attempted to predict which 
patients are at high risk. Callaham developed an algo- 
rithm based on clinical and ECG criteria, that identi- 
fies patients who are at high risk of major complica- 
tions after TCA overdose.’ Boehnert and Lovejoy 
reported that the QRS duration is a useful predictor 
of seizures and ventricular dysrhythmias after TCA 
overdose.8 We combined these guidelines into a single 
algorithm and tested them on all patients who were 
evaluated for TCA overdose at the University of 
Michigan Medical Center between 1982 and 1985. 
The specific objective of this study was to determine 
if the modified algorithm would retrospectively iden- 
tify patients with both complicated and uncomplicat- 
ed TCA overdose. 
METHODS 
We reviewed the care of all patients with TCA over- 
dose at the University of Michigan hospitals between 
January 1982 and September 1985. Patients were 
identified by reviewing the final diagnoses recorded in 
the emergency department logs and by a computer- 
ized search for the registration numbers of all pa- 
tients with ICD-9 code 969.0 who were admitted to 
the hospital. First, the records of all patients with the 
diagnosis of “drug overdose,” “tricyclic overdose,” or 
overdose with a specifically named antidepressant 
were obtained. To be included in the study, the pa- 
tient’s record needed specific documentation that the 
ingestion had been witnessed or that there were mea- 
surable drug levels of TCAs in blood or urine speci- 
mens. From the chart, we estimated the amount of 
TCA ingested, the time from ingestion to arrival at 
the hospital, the presence of major clinical signs or 
symptoms (hypotension, coma, seizure, respiratory 
depression, dysrhythmia, or death) as well as late 
complications and ultimate outcome. The QRS dura- 
tion on the initial ECG was also recorded to deter- 
mine if it could predict the occurrence of seizures or 
ventricular dysrhythmias. Initial therapy such as gas- 
tric emptying, charcoal administration, and use of 
cathartics was also determined. Finally, the data were 
used to test the clinical algorithm in Figure 1. 
The algorithm is identical to the one proposed by 
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Figure 1. Algorithm for managing patients with tricyclic anti- 
depressant overdosage. Adapted from Callaham.7 
Callaham,’ with one exception. The qualitative term 
“conduction blocks,” has been replaced by “QRS> 
0. lo”- a more specific term used by Boehnert and 
Lovejoy. Although there was no specific documenta- 
tion about bowel sounds other than at the time of 
admission in most patients, we assumed that patients 
who had no symptoms and developed no complica- 
tions would have had normal bowel sounds at six 
hours. 
The method of Hanley and Lippman-Hand was 
used to calculate 95% confidence intervals around 
the observed rate of complications. When zero com- 
plications are observed, the 95% confidence intervals 
equal 3/N, where N equals the number of cases in the 
study.” 
RESULTS 
Of the 48 patients identified as TCA overdoses, 
45(93%) had complete records that could be used to 
validate the algorithm. The majority (60%) of our 
patients were women and 68% of patients were be- 
tween the ages of 18 and 40. A total of 58% of pa- 
tients ingested other agents (most often alcohol and 
benzodiazapines) in addition to TCAs; the remaining 
42% of patients ingested only TCAs. Estimated time 
from ingestion to presentation also varied widely, al- 
though 60% were evaluated less than six hours after 
ingestion. The TCAs ingested by our patients includ- 
ed amitriptyline, nortriptyline, imipramine, desi- 
pramine, and doxepin. The estimated amounts of in- 
gested TCAs also varied widely, but it was estimated 
that one half of patients had ingested L 1,000 mg of 
the various TCAs. Of the 45 patients reviewed, 44 
were admitted to the intensive care unit. Only one 
patient was discharged from the emergency depart- 
ment (ED); this patient presented without symptoms 
20 h after ingestion of 300 mg of doxepin (only twice 
the recommended therapeutic daily dose). The pre- 
senting signs and symptoms of all patients are shown 
in Table 1. 
All patients had cardiac monitoring and a 12-lead 
ECG in the ED. Initial therapy with gastric emptying 
(by ipecac or lavage), activated charcoal, and cathar- 
sis was documented in 32 of 48 patients. Ten patients 
received ipecac and charcoal (no documentation of 
catharsis), and two patients received only ipecac (no 
documentation of charcoal or catharsis). There was 
no documentation of gastric emptying, charcoal ad- 
ministration, or catharsis in one patient. 
COMPLICATIONS 
Of the 17 patients who presented with major signs or 
symptoms, 14 developed no further complications. In 
the remaining three patients, one developed seizures, 
one developed respiratory depression that required 
ventilatory support for approximately 48 h, and one 
developed aspiration pneumonia that required pro- 
longed hospitalization. 
In our population, no complications developed af- 
ter the first 24 h of hospitalization. All of the patients 
had constant cardiac monitoring; none developed 
malignant ventricular dysrhythmias. All patients 
were ultimately discharged alive and well after receiv- 
ing appropriate psychiatric care. 
ELECTROCARDIOGRAMS 
We also evaluated how the results of ECG alone 
would predict the development of seizures and ven- 
tricular dysrhythmias. Twenty-eight patients had a 
QRS duration less than 0.10 s; none of these patients 
developed seizure activity or ventricular dysrhyth- 
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Table 1. Signs and Symptoms at Time of Presentation 
to the ED 
Number of 
Signs or Symptoms Patients 
None 28 
Serious toxicity* 17 
Coma 12 
Seizure 1 
Respiratory depression a 
Systolic blood pressure (<90 mm Hg) 4 
Dysrhythmia 0 
‘Since some of the patients had multiple complications, the sum of the 
Individual signs and symptoms is greater than 17. 
mias. Seventeen patients had a QRS duration between 
0.10 and 0.16 s; two of these patients had seizure 
activity but none experienced ventricular dysrhyth- 
mias. No patients had a QRS duration greater than 
0.16 s. 
VALIDATION OF ALGORITHM 
We next attempted to validate the modified algorithm 
shown in Figure 1. Of the 45 patients, 25 (55%) 
would have been admitted immediately or within six 
hours of presentation because they developed major 
signs or symptoms of TCA poisoning or had a pro- 
longed QRS interval. This group included 17 patients 
with major signs at the time of presentation, as 
shown in Table 1. One patient presented without ma- 
jor signs or symptoms but developed coma and respi- 
ratory depression within six hours of presentation. 
Seven patients were without major signs or symptoms 
but had an initial QRS duration of greater than 0.10 s. 
Twenty patients (45%) would have been discharged 
from the ED after six hours of observation (assuming 
normal bowel sounds were present). None of these 20 
asymptomatic patients had complications during 
their hospital courses. The 95% confidence interval 
around this observation is 0 to 15 %. 
DISCUSSION 
Patients who ingest overdoses of TCAs are customari- 
ly admitted to the hospital since even patients who are 
initially asymptomatic may develop complications at 
a later time. Previous work has shown that serum 
TCA levels do not correlate with ultimate outcome or 
prognosis.‘,x QRS duration of greater than 0.10 s in 
combination with TCA blood levels has been utilized 
in the past to predict the “seriousness” of TCA over- 
dose; however, it is only recently that the value of the 
ECG has been further clarified.8 
Despite these shortcomings, admission criteria for 
patients with suspected or reported TCA overdose 
have been proposed. In 1982 Callaham advocated six- 
hour management of TCA overdoses in the emergen- 
cy department to identify complicated versus un- 
complicated TCA overdoselo; in 1985 he published a 
clinical algorithm by which these patients could be 
evaluated. Six hours were felt to be an appropriate 
length of observation since all reported patients who 
died from TCA overdose developed major signs of 
toxicity within two hours of presentation to the 
ED.‘,” Although Callaham’s algorithm seems sensi- 
ble and clinically useful, no studies that test the valid- 
ity of the algorithm have been reported. Our study 
determined applicability and validity of Callaham’s 
algorithm to another patient population and also 
modified the algorithm by including specific criteria 
for a prolonged QRS interval. 
One of the major principles in the algorithm is the 
use of six hours of observation to identify patients at 
risk for complications. This concept appeared to be 
useful in our patients. Seventeen patients had evi- 
dence of major TCA toxicity on arrival to the ED; 
one of them developed further complications within 
six hours of arrival. Similarly, of the 28 patients who 
presented without major signs, the only patient who 
developed life-threatening complications did so with- 
in six hours of presentation. Although there are many 
case reports of patients who have developed late com- 
plications of TCA overdose, these complications 
seem to occur in patients who have obvious toxicity at 
presentation or who have been given inadequate ther- 
apy in the ED.” Almost all (42/45) of our patients 
had documentation of initial therapy-gastric empty- 
ing and administration of activated charcoal.” All 
patients in our study who experienced complications 
attributable to TCA overdose did so within six hours. 
Therefore our data supports the concept that late 
complications do not occur in properly treated pa- 
tients who do not have obvious early evidence of 
toxicity. 
The inclusion of specific criteria for a prolonged 
QRS duration deserves comment. Seven patients who 
otherwise had no evidence of toxicity had a QRS du- 
ration of greater than 0.1 s. None of these patients 
developed seizures or dysrhythmias. However, pre- 
vious studies of larger numbers of patients do suggest 
that these patients, especially those with a QRS dura- 
tion greater than 0.16 s, are at risk of complica- 
tions.R Since we had no patients with such a pro- 
longed QRS, we are unable to comment on the 
validity of that predictor of complications. We should 
also note that application of the QRS criteria without 
considering the clinical status of the patient is inap- 
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propriate. Some of the patients with evidence of tox- 
icity did not have prolonged QRS intervals in their 
initial ECG. . 
It is important to define the limitations of this 
retrospective and relatively small study. Retrospective 
studies inherently have missing data, either of clinical 
information or of follow-up. As suggested by oth- 
ers,‘-’ missing information may be less of a problem 
for studies of patients admitted to intensive care 
units. We had adequate information on 45 of the 48 
records and since 44/45 were admitted to intensive 
care units, we are confident that we identified major 
complications. The one piece of information that was 
missing in most of the records was the presence or 
absence of bowel sounds at six hours. However, the 
assumption that bowel sounds were present in the 
uncomplicated ingestions does not affect our conclu- 
sions, since none of these patients developed 
complications. 
tients in our study. The algorithm identified 20 pa- 
tients who were at low risk for complications, and 
none of them developed complications. The 95% 
confidence intervals around this observation are rela- 
tively wide, 0 to 15%. Larger studies should be per- 
formed to obtain narrower confidence intervals that 
estimate the safety of using the algorithm to manage 
patients with TCA overdose. 
The common practice of admitting nearly all pa- 
tients to intensive care units is based on rare case 
reports of late complications developing in asympto- 
matic patients. Our study and others suggest that late 
complications do not develop in patients who are giv- 
en adequate therapy and who have no initial evidence 
of toxicity. Further work needs to be done to evaluate 
safe strategies for managing patients with TCA over- 
dose. We conclude that the modified algorithm is 
clinically reasonable and is suitable for testing with 
large numbers of patients in a prospective fashion. 
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